Other OTC - Delayed Quote USD

Nutra Pharma Corp. (NPHC)

0.0001 0.0000 (0.00%)
As of April 22 at 12:03 PM EDT. Market Open.

Key Executives

Amounts are as of December 31, 2021 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
NameTitlePayExercisedYear Born
Dr. Dale Vander Putten MBA, Ph.D. Chief Scientific Officer 144k -- 1959
Dr. Michael D. Flax D.D.S., M.S., P.A. CEO, CFO & Chairman -- -- 1956
Joe Lucas Vice President of Operations -- -- --
Ms. Nina Goldstein Secretary -- -- 1960

Nutra Pharma Corp.

1537 NW 65th Avenue
Plantation, FL 33313
United States
954 509 0911 https://www.nutrapharma.com
Sector: 
Healthcare
Full Time Employees: 
4

Description

Nutra Pharma Corp., a biopharmaceutical company, acquires, licenses, and commercializes pharmaceutical products and technologies, and homeopathic and ethical drugs for the management of pain, neurological disorders, cancer, and autoimmune and infectious diseases primarily in the United States. The company offers Nyloxin and Nyloxin Extra Strength products, which are used as an oral spray for treating lower back pain, migraines, neck aches, shoulder pain, cramps, and neuropathic pain, as well as a topical gel for treating joint pain, and pain associated with arthritis and repetitive stress; Pet Pain-Away, a homeopathic, non–narcotic, non–addictive, and over–the–counter pain reliever to treat chronic pain in companion animals; Luxury Feet, an over-the-counter pain reliever and anti–inflammatory product to treat pain or discomfort due to high heels and stilettos; Nyloxin Military Strength for treating pain to the United States Military and Veteran's Administration; and Equine Pain-Away, an over-the-counter topical pain reliever to relieve pain in horses. It is also involved in developing RPI-78M to treat neurological diseases and autoimmune diseases, including multiple sclerosis, adrenomyeloneuropathy, amyotrophic lateral sclerosis, rheumatoid arthritis, and myasthenia gravis; RPI-MN to treat viral diseases comprising human immunodeficiency virus/AIDS and herpes, as well as for general anti-viral applications; RPI-78 for pain and arthritis; and RPI-70 for pain. The company was incorporated in 2000 and is based in Plantation, Florida.

Corporate Governance

Nutra Pharma Corp.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Recent Events

Upcoming Events

Related Tickers

STSN Stemsation International, Inc.
0.0200
0.00%
 
TLPH Talphera, Inc.
0.9400
+1.08%
 
AQST Aquestive Therapeutics, Inc.
4.3450
-0.80%
 
CRON Cronos Group Inc.
2.4850
+5.30%
 
TLRY.TO Tilray Brands, Inc.
2.5400
+8.09%
 
SBFM Sunshine Biopharma, Inc.
1.1850
-17.65%
 
TCNNF Trulieve Cannabis Corp.
10.69
+0.80%
 
ACB.TO Aurora Cannabis Inc.
10.03
+17.17%
 
CGC Canopy Growth Corporation
9.06
+15.35%